Northshore Health Centers, Inc. | |
1275 E North St Ste 102, Crown Point, IN 46307-3538 | |
(219) 763-8112 | |
(219) 764-5380 |
Full Name | Northshore Health Centers, Inc. |
---|---|
Type | Facility |
Speciality | Clinic/center - Federally Qualified Health Center (fqhc) |
Location | 1275 E North St Ste 102, Crown Point, Indiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1609562370 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Northshore Health Centers, Inc. Po Box 1430, Portage, IN 46368-9230 Ph: (219) 763-8112 | Northshore Health Centers, Inc. 1275 E North St Ste 102, Crown Point, IN 46307-3538 Ph: (219) 763-8112 |
News Archive
Researchers at Duke University Medical Center may have a new way to stop and even prevent the urinary tract infections (UTIs) that plague more than a third of all adults, some of them repeatedly.
A researcher in the United States says a ten year study into the eating disorder anorexia nervosa suggests that sufferers may have a genetic predisposition for it.
When 225 researchers from around the world convened in Miami to exchange the latest on β amyloid positron emission tomography in January, there was a palpable sense of urgency. At the 6th Annual Human Amyloid Imaging (HAI) Conference, the possibility of approval, potentially within months, of the first amyloid-scanning compound for clinical use hung over the room.
A study describing how cells within blood vessel walls move en masse overturns an assumption common in the age of genomics - that the proteins driving cell behavior are doing so much multitasking that it would be near impossible to group them according to a few discrete functions.
Adaptimmune Therapeutics plc, a clinical stage biopharmaceutical company focused on the use of T-cell therapy to treat cancer, today announced that data from its Phase I/II study of its affinity enhanced T-cell receptor therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published in Nature Medicine.
› Verified 2 days ago